385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module

2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous AND/OR transdermal dosage form	Is a	Type of drug preparation	false	Inferred relationship	Existential restriction modifier
Cutaneous AND/OR transdermal dosage form	Is a	Dose form by site prepared for	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Coal tar extract 2% shampoo 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzoyl peroxide 5% / Erythromycin 3% gel 23.3 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Neomycin 0.5% / Chlorhexidine hydrochloride 0.1% cream 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Tacalcitol 4micrograms/g ointment 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel 112 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Crotamiton 10% cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Glyceryl trinitrate 10mg/24hours patches 28 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% cream 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clioquinol 3% / Hydrocortisone 1% ointment 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicotine 21mg/24hours patches 14 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Diflucortolone 0.1% oily cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Econazole 1% / Hydrocortisone 1% cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream 7.5 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% gel 40 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 5% gel 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Beclometasone 0.025% ointment 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Miconazole 2% / Hydrocortisone 1% cream 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Azelaic acid 20% cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Salicylic acid 11% / Lactic acid 4% gel 5 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% cream 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fluocinolone 0.025% cream 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fluorouracil 5% cream 20 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone valerate 0.025% cream 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Felbinac 3% gel 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dimeticone 22% / Benzalkonium chloride 0.1% cream 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fluticasone 0.05% cream 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Emulsifying ointment 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clobetasol 0.05% cream 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicotine 21mg/24hours patches 21 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Coal tar extract 2% shampoo 125 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mometasone 0.1% cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzoyl peroxide 5% gel 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Tretinoin 0.01% gel 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Sodium fusidate 2% ointment 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Beclometasone 0.025% cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fluocinolone 0.025% ointment 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aqueous cream 4 kg	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Betamethasone dipropionate 0.05% cream 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Penciclovir 1% cream 2 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aqueous calamine cream 100 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clotrimazole 1% cream 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Benzoyl peroxide 5% cream 40 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone butyrate 0.1% ointment 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clioquinol 3% / Betamethasone valerate 0.1% ointment 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 10% gel 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mometasone 0.1% ointment 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fluocinolone 0.025% gel 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nystatin 100,000units/g cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Adapalene 0.1% cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mometasone 0.1% ointment 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Crotamiton 10% cream 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 5% gel 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clobetasol 0.05% ointment 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Magnesium sulphate paste 500 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Salicylic acid 2% / Mucopolysaccharide polysulphate 0.2% cream 80 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Desoximetasone 0.05% oily cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cetrimide 0.2% / Benzalkonium chloride 0.01% cream 200 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Salicylamide 5% / Benzocaine 2% gel 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clobetasol 0.05% cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Selenium sulphide 2.5% shampoo 150 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 50micrograms/hour patches 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 75micrograms/hour patches 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Durogesic 75 transdermal patches (Janssen-Cilag Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 25micrograms/hour patches 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Durogesic 25 transdermal patches (Janssen-Cilag Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Metronidazole 0.8% gel 15 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Metronidazole 0.8% gel 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Metronidazole 0.8% gel 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Metrotop 0.8% gel (Medlock Medical)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 100micrograms/hour patches 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Durogesic 100 transdermal patches (Janssen-Cilag Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Metronidazole 0.75% cream 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Metronidazole 0.75% cream 40 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Rozex 0.75% cream (Galderma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Glyceryl trinitrate 2% ointment 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Percutol 2% ointment (Pliva Pharma Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 25micrograms/24hours patches 8 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 25micrograms/24hours patches 24 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Evorel 25 patches (Theramex HQ UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estraderm TTS 25 patches (Novartis Pharmaceuticals UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estraderm MX 25 patches (Norgine Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dermestril 25 patches (Strakan Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 40micrograms/24hours patches 8 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Elleste Solo MX 40 transdermal patches (Viatris UK Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fematrix 40 patches (Solvay Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 80micrograms/24hours patches 8 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Diclofenac diethylammonium 1.16% gel 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Diclofenac diethylammonium 1.16% gel 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Elleste Solo MX 80 transdermal patches (Viatris UK Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Voltarol 1.16% Emulgel P (Haleon UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fematrix 80 patches (Solvay Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Voltarol 1.16% Emulgel (Haleon UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Alclometasone 0.05% cream 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Modrasone 0.05% cream (Pliva Pharma Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 37.5micrograms/24hours patches 8 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Alclometasone 0.05% ointment 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier

Start Previous Page 19 of 55 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479527018	Cutaneous AND/OR transdermal dosage form	en	Synonym	Active	Only initial character case insensitive	SNOMED CT core module
2660179010	Cutaneous AND/OR transdermal dosage form (qualifier value)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT core module